We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Proteinuria Determined by Automated Analyzer

By LabMedica International staff writers
Posted on 03 Jul 2012
A rapid, accurate, and cost-effective method for their detection of protein in urine has been developed for the autoanalyzer. More...


The method is a two-reagent system consists of a buffer solution and surfactants, and a second one consists of a dye solution of Erythrosin B being added to a urine sample, and the dye bound protein is measured by a spectrophotometer.

At the Juntendo University (Tokyo, Japan) nephrologists enrolled 70 outpatients who were screened for proteinuria by the dipstick test. Spot urine samples from the patients and 79 healthy volunteers were examined. Urine samples were stored at -80 °C. A solution containing a buffer agent with a pH 2.3 and surfactants and a solution of Erythrosin B are added to each urine sample. After letting the mixture stand for five minutes at 37 °C, the dye-bound protein is measured by a spectrophotometer at 546 nm using an automated analyzer.

The calibration curve was linear with human serum albumin concentration in the range of 2.4-200 mg/L. The detection limit, 2.4 mg/L was superior to conventional dye-binding methods by one order of magnitude and comparable to the turbidimetric immunoassay (TIA), which is quite expensive. There was an excellent correlation between the results given by the Erythrosin B (Wako Pure Chemical Industries Ltd., Tokyo, Japan) method and those by the TIA.

The authors concluded that the method is equal to the dipstick test in terms of time and cost savings. The reaction was completed within 5 minutes at 37 °C after mixing the test solution, and could be coupled with the 7170S automated analyzer (Hitachi, Tokyo, Japan) for rapid detection. The method was capable of determining actual samples without being influenced by foreign substances in urine such as urea, creatinine, and glucose. This method is sufficiently sensitive for the detection of trace proteinuria in early-stage of chronic kidney disease, and is directly applicable to actual samples. The study was published in the July 2012 issue of the journal Clinica Chimica Acta.

Related Links:

Juntendo University
Wako Pure Chemical Industries Ltd.
Hitachi




Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Hematology Consumables
Bioblood Devices
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.